Inspire Medical Systems (INSP) Stock Price, News & Analysis

Company Overview

Inspire Medical Systems, Inc. is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve. The device received FDA approval in 2014 and has since obtained CE mark authorization for marketing in Europe. Inspire collaborates with a network of accredited sleep centers and specialized physicians to identify eligible patients and provide training, support and follow-up care.

Founded in 2007 and headquartered in Golden Valley, Minnesota, Inspire Medical Systems serves markets across North America and Europe, with ongoing efforts to expand its commercial footprint in select international regions. The company is led by President and Chief Executive Officer Michael A. Moulder, supported by a management team with deep expertise in medical devices, regulatory affairs and commercial operations. Inspire remains focused on advancing its technology platform through clinical research, product enhancements and expanded physician education programs.

Key Stats

• Today's Range: $45.57 to $48.40
• 50-Day Range: $48.24 to $68.12
• 52-Week Range: $44.41 to $163.35
• Volume: 762,605 shs
• Average Volume: 1.21 million shs
• Market Capitalization: $1.32 billion
• P/E Ratio: 10.16
• Dividend Yield: N/A
• Price Target: $85.00
• Consensus Rating: Hold

Inspire Medical Systems Stock Analysis - MarketRank™

Inspire Medical Systems scored higher than 91% of companies evaluated by MarketBeat, and ranked 43rd out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Hold

Consensus Rating

Inspire Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.15, and is based on no strong buy ratings, 4 buy ratings, 15 hold ratings, and 1 sell rating.

Upside Potential

Inspire Medical Systems has a consensus price target of $85.00, representing about 79.5% upside from its current price of $47.35.

Amount of Analyst Coverage

Inspire Medical Systems has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 35.71%

Earnings Growth

Earnings for Inspire Medical Systems are expected to grow by 35.71% in the coming year, from $1.82 to $2.47 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Inspire Medical Systems is 10.52, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.28.

Price to Earnings Ratio vs. Sector

The P/E ratio of Inspire Medical Systems is 10.52, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.02.

Price to Earnings Growth Ratio

Inspire Medical Systems has a PEG Ratio of 2.83. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Inspire Medical Systems has a P/B Ratio of 1.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

10.26% of the float of Inspire Medical Systems has been sold short.

Short Interest Ratio / Days to Cover

Inspire Medical Systems has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Inspire Medical Systems has recently decreased by 9.78%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Inspire Medical Systems does not currently pay a dividend.

Dividend Growth

Inspire Medical Systems does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.65

News Sentiment

Inspire Medical Systems has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 33 news articles for Inspire Medical Systems this week, compared to 11 articles on an average week.

Search Interest

Only 8 people have searched for INSP on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.

MarketBeat Follows

3 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Inspire Medical Systems insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.20% of the stock of Inspire Medical Systems is held by insiders.

Percentage Held by Institutions

94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

INSP Stock Analysis - Frequently Asked Questions

How have INSP shares performed this year?

Inspire Medical Systems' stock was trading at $92.20 on January 1st, 2026. Since then, INSP shares have decreased by 48.6% and is now trading at $47.3450.

How were Inspire Medical Systems' earnings last quarter?

Inspire Medical Systems, Inc. (NYSE:INSP) posted its earnings results on Monday, May, 4th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of ($0.28) by $0.38. The business's quarterly revenue was up 1.6% on a year-over-year basis.
Read the conference call transcript.

How will Inspire Medical Systems' stock buyback program work?

Inspire Medical Systems' Board of Directors initiated a stock buyback program on Monday, August 11th 2025, which permits the company to repurchase $200,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 8.6% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's leadership believes its shares are undervalued.

When did Inspire Medical Systems IPO?

Inspire Medical Systems (INSP) raised $101 million in an initial public offering on Thursday, May 3rd 2018. The company issued 6,750,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Who are Inspire Medical Systems' major shareholders?

Inspire Medical Systems' top institutional investors include Assenagon Asset Management S.A. (1.81%), Y Intercept Hong Kong Ltd (0.55%), Bank of New York Mellon Corp (0.52%) and Wasatch Advisors LP (0.48%). Insiders that own company stock include Timothy P Herbert, Richard Buchholz, Shawn Mccormick, John Rondoni, Jerry C Griffin, Randy Ban, Steven Jandrich and Myriam Curet.
View institutional ownership trends.

How do I buy shares of Inspire Medical Systems?

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Inspire Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Inspire Medical Systems investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), UnitedHealth Group (UNH), Tesla (TSLA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

Company Calendar

• Last Earnings: 5/04/2026
• Today: 5/06/2026
• Bank of America Global Healthcare Conference 2026: 5/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:INSP
• CIK: 1609550
• Web: www.inspiresleep.com
• Phone: (844) 672-4357
• Fax: N/A
• Employees: 1,333
• Year Founded: 2007

Price Target and Rating

• Average Price Target for Inspire Medical Systems: $85.00
• High Price Target: $197.00
• Low Price Target: $45.00
• Potential Upside/Downside: +85.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.15
• Research Coverage: 20 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.98
• Trailing P/E Ratio: 10.21
• Forward P/E Ratio: 25.19
• P/E Growth: 2.83
• Net Income: $145.42 million
• Net Margins: 14.33%
• Pretax Margin: 7.20%
• Return on Equity: 10.66%
• Return on Assets: 9.00%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.08
• Quick Ratio: 4.56

Sales & Book Value

• Annual Sales: $911.98 million
• Price / Sales: 1.45
• Cash Flow: $2.39 per share
• Price / Cash Flow: 19.15
• Book Value: $26.88 per share
• Price / Book: 1.71

Miscellaneous

• Outstanding Shares: 28,790,000
• Free Float: 28,161,000
• Market Cap: $1.32 billion
• Optionable: Optionable
• Beta: 0.83